1.
Nuclear EGFR-PKM2 axis induces cancer stem cell-like characteristics in irradiation-resistant cells
by Shi, Ying
Cancer letters, 2018-05-28, Vol.422, p.81-93
2.
MicroRNA-30a suppresses autophagy-mediated anoikis resistance and metastasis in hepatocellular carcinoma
by Fu, Xiu-Tao
Cancer letters, 2018-01-01, Vol.412, p.108-117
3.
FAT1 prevents epithelial mesenchymal transition (EMT) via MAPK/ERK signaling pathway in esophageal squamous cell cancer
by Hu, Xiaoling
Cancer letters, 2017-07-01, Vol.397, p.83-93
4.
miR-93-5p/IFNAR1 axis promotes gastric cancer metastasis through activating the STAT3 signaling pathway
by Ma, Dong-Hong
Cancer letters, 2017-11-01, Vol.408, p.23-32
5.
Tumor suppressive microRNA-124a inhibits stemness and enhances gefitinib sensitivity of non-small cell lung cancer cells by targeting ubiquitin-specific protease 14
by Yu, Fei
Cancer letters, 2018-07-28, Vol.427, p.74-84
6.
SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosis in vitro and inhibits tumor growth in vivo
by Xia, Yong
Cancer letters, 2014, Vol.355 (2), p.297-309
7.
Cyclooxygenase-2 expression in squamous dysplasia and squamous cell carcinoma of the esophagus
by Yu, Hong-Ping
Cancer letters, 2003, Vol.198 (2), p.193-201
8.
Oncogenic B-Raf(V600E) abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells
by Zhang, Ling
Cancer letters, 2013-08-28, Vol.337 (1), p.125-132
9.
Oncogenic B-RafV600E abrogates the AKT/B-Raf/Mps1 interaction in melanoma cells
by Zhang, Ling
Cancer letters, 2013, Vol.337 (1), p.125-132
10.
SKLB316, a novel small-molecule inhibitor of cell-cycle progression, induces G2/M phase arrest and apoptosisin vitroand inhibits tumor growthin vivo
by Yong Xia
Cancer letters, 2014-12-28, Vol.355 (2), p.297
11.
Oncogenic B-RafV600Eabrogates the AKT/B-Raf/Mps1 interaction in melanoma cells
by Ling Zhang
Cancer letters, 2013-08-28, Vol.337 (1), p.125
12.
